Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/13/2002WO2002046730A2 System and method for measuring the dielectric strength of a fluid
06/13/2002WO2002046722A2 Method for diagnosing pathology in biological samples
06/13/2002WO2002046721A2 Optical discs for measuring analytes
06/13/2002WO2002046718A2 Method of testing adequacy of specimen cells
06/13/2002WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer
06/13/2002WO2002046476A2 Genotyping using partially-complementary probes
06/13/2002WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002WO2002046470A2 Testing endosymbiont cellular organelles and compounds identifiable therewith
06/13/2002WO2002046468A2 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
06/13/2002WO2002046467A2 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
06/13/2002WO2002046466A2 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer
06/13/2002WO2002046464A2 Ligand detection method
06/13/2002WO2002046461A2 Method for identifying modulators of transcription
06/13/2002WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
06/13/2002WO2002046451A2 Methods for the identification of inhibitors of cysteine syhthase in plants
06/13/2002WO2002046448A2 Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers
06/13/2002WO2002046439A2 A novel root specific promoter driving the expression of a novel lrr receptor-like kinase
06/13/2002WO2002046431A1 Model for hematopoietic cell growth, differentiation and disease
06/13/2002WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
06/13/2002WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
06/13/2002WO2002046418A2 Lipid-associated molecules
06/13/2002WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells
06/13/2002WO2002046414A2 Human g-protein coupled receptor expressed highly in kidney
06/13/2002WO2002046411A2 Intestinal proteins
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002WO2002046399A2 Mutated class i major histocompatibility proteins and complexes
06/13/2002WO2002046392A2 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046385A2 Enzymes
06/13/2002WO2002046384A2 Kinases and phosphatases sequences, and use thereof
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002WO2002046381A2 Method for the prevention or reduction of haze in beverages
06/13/2002WO2002046375A1 In vitro synthesis of a layered cell sorted tissue
06/13/2002WO2002046356A1 Apparatus for treating sample in microamount
06/13/2002WO2002046355A1 Well unit for detecting cell chemotaxis and separating chemotactic cells
06/13/2002WO2002046234A1 Cocaine haptens
06/13/2002WO2002046232A2 Multimeric single-chain antibody with multiple antigen binding
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046222A2 Compositions and methods for diagnosing alzheimer's disease
06/13/2002WO2002046221A2 Human protein differentially expressed in alzheimer's disease's brain
06/13/2002WO2002046219A2 Rho-gtpase activating proteins and methods related thereto
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002045842A1 Linear array devices for detecting an analyte or for screening
06/13/2002WO2002045835A2 Microelectronic arrays for cell-based functional genomics / high throughput phenotyping by electrokinetic assembly
06/13/2002WO2002045570A2 Methods and compositions for the diagnosis and treatment of viral disease using 55092
06/13/2002WO2002045524A2 Prolyl endoprotease from aspergillus niger
06/13/2002WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/13/2002WO2002045506A1 Drug screening system
06/13/2002WO2002033402A3 Establishment of biological cut-off values for predicting resistance to therapy
06/13/2002WO2002031469B1 Exhaust gas particulate mass measurement apparatus with real-time moisture monitor
06/13/2002WO2002031464A3 Evaluating binding affinities by force stratification and force planning
06/13/2002WO2002026934A3 System and process for validating, aligning and reordering genetic sequence maps using ordered restriction map
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002025267A3 Method and apparatus for rapid determination of polymer molecular weight
06/13/2002WO2002023194A3 Fluorescence polarization-based homogeneous assay for fumonisin determination in grains
06/13/2002WO2002022007A3 Chemical sensing instrument and related method of use
06/13/2002WO2002020554A3 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
06/13/2002WO2002020416A3 Polyhydroxyalkanoate levels as an indicator of bioreactor health
06/13/2002WO2002017948A3 Control of crop pests and animal parasites through direct neuronal uptake
06/13/2002WO2002014535A3 Electrochemical strip test for small volumes
06/13/2002WO2002014532A3 Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002010740A3 Quantitative analysis of hexose-monophosphates from biological samples
06/13/2002WO2002008763A3 Immunosensor
06/13/2002WO2002004947A3 Spectrophotometric system and method for the identification and characterization of a particle in a bodily fluid
06/13/2002WO2002003072A3 A method for extracting quantitative information relating to interactions between cellular components
06/13/2002WO2002002054A3 Methods and compositions for the diagnosis of schizophrenia
06/13/2002WO2001096879A3 Method and apparatus for monitoring anti-platelet agents
06/13/2002WO2001096878A3 Marker for neurodegerative diseases and its use in drug screening
06/13/2002WO2001096377A3 Vaccine for congenital tremors in pigs
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001090614A3 Surface tension valves for microfluidic applications
06/13/2002WO2001090188A3 Receptor-based interaction trap
06/13/2002WO2001087981A3 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
06/13/2002WO2001079852A3 Nmr-methods for indentifying sites in papillomavirus e2 protein
06/13/2002WO2001077674A3 Fluorescent hplc assay for 20-hete and other p-450 metabolites of arachidonic acid
06/13/2002WO2001077372A3 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
06/13/2002WO2001075438A3 Electrically-conductive patterns for monitoring the filling of medical devices
06/13/2002WO2001071360A3 Prostate cancer markers
06/13/2002WO2001071312A3 Apparatus and method for electrophysiological testing
06/13/2002WO2001059103A3 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
06/13/2002WO2001053526A3 Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions
06/13/2002WO2001051663A3 Integrated systems and methods for diversity generation and screening
06/13/2002WO2001040798A3 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
06/13/2002WO2001029256A3 Cephalic pain susceptibility marker
06/13/2002WO2001010444A3 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate
06/13/2002WO2000079009A9 Improved primers and methods for the detection and discrimination of nucleic acids
06/13/2002WO2000079008A9 High throughput assay system
06/13/2002WO2000078455A9 Devices and methods for the performance of miniaturized in vitro amplification assays
06/13/2002WO2000077262A9 Synthetic ligation reassembly in directed evolution
06/13/2002WO2000075956A3 Infra-red light source
06/13/2002WO2000067017A9 Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy
06/13/2002US20020073441 Polypeptide for use in treatment of Alzheimer's, Parkinson's, Huntington's, spino-cerebellar ataxias, muscular disorders, multiple sclerosis, blood disorders, reperfusion injury, arthritis and graft vs host disorder
1 ... 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 ... 3937